BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.67), $0.31 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $33.01 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.